目录产品 » SARS-CoV-2 RBD Neutralization Antibody (R323IgM)

SARS-CoV-2 RBD Neutralization Antibody (R323IgM)

SARS-CoV-2 RBD Neutralization Antibody (R323IgM)
V80302
询价

联系我们
Description

SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as 2019-nCoV, is a positive-sense single-stranded RNA virus. Neutralizing antibodies against SARS-CoV-2 can block the interaction between SARS-CoV-2 RBD and ACE2. It can be used in the assessment and development of assays for the detection and quantitation of SARS-CoV-2 neutralizing antibodies.

Specificity SARS-CoV-2 Spike Protein S1 subunit and its RBD domain

Production
Cultured in vitro under conditions free from animal-derived components
Purification Affinity chromatography
Formulation PBS, pH 7.2, containing 0.02% sodium azide.
Concentration ≥ 2 mg/ml
Clone ID R323IgM

Target Background SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as 2019-nCoV, is a positive-sense single-stranded RNA virus. Neutralizing antibodies against SARS-CoV-2 can block the interaction between SARS-CoV-2 RBD and ACE2. It can be used in the assessment and development of assays for the detection and quantitation of SARS-CoV-2 neutralizing antibodies.

喜欢新升级的网站吗?

讨厌

不喜欢

一般

喜欢

非常喜欢

*